Resources
Clinical Validation of a Multimodal Artificial Intelligence Prognostic Model in Localized and Advanced Disease
Artera has developed multimodal AI (MMAI)-enabled predictive and prognostic biomarkers for patients with prostate cancer usin [...]
Resources
ArteraAI Predictive Models
ArteraAI is a leading precision medicine company developing AI tests to personalize cancer therapy. Download the pdf.